Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 79 of 235 for:    CALCITONIN SALMON

Pembrolizumab in Recurrent or Metastatic Medullary Thyroid Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03072160
Recruitment Status : Suspended (IRB suspended enrollment on 12/18/18)
First Posted : March 7, 2017
Last Update Posted : August 22, 2019
Sponsor:
Information provided by (Responsible Party):
National Institutes of Health Clinical Center (CC) ( National Cancer Institute (NCI) )

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Suspended
Estimated Primary Completion Date : December 1, 2019
Estimated Study Completion Date : December 1, 2021